Brief: Sensorion/OTOF-GT: FDA Grants Pediatric Disease Designation For Treatment Of Otoferlin Gene-Mediated Hearing Loss

Sensorion SA

07/11/2022 06:33

Nov 7 (Reuters) - Sensorion SA  ALSEN.PA :
    * US FDA GRANTS RARE PEDIATRIC DISEASE DESIGNATION TO
OTOF-GT FOR
THE TREATMENT OF OTOFERLIN GENE-MEDIATED HEARING LOSS
    * SENSORION IS ON TRACK TO LE A CTA FOR OTOF-GT IN H1 2023

Source text: https://bit.ly/3FLOzYl
Further company coverage:  ALSEN.PA 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))